Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 73

1.

The influence of parents and schools on developmental trajectories of antisocial behaviors in Caucasian and African American youths.

Morrison RA, Martinez JI, Hilton EC, Li JJ.

Dev Psychopathol. 2019 Oct;31(4):1575-1587. doi: 10.1017/S0954579418001335.

PMID:
30554576
2.

Suicide Among Persons With Dementia, Georgia, 2013 to 2016.

Annor FB, Bayakly RA, Morrison RA, Bryan MJ, Gilbert LK, Ivey-Stephenson AZ, Holland KM, Simon TR.

J Geriatr Psychiatry Neurol. 2019 Jan;32(1):31-39. doi: 10.1177/0891988718814363. Epub 2018 Nov 26.

PMID:
30477384
3.

Vagus nerve stimulation intensity influences motor cortex plasticity.

Morrison RA, Hulsey DR, Adcock KS, Rennaker RL 2nd, Kilgard MP, Hays SA.

Brain Stimul. 2019 Mar - Apr;12(2):256-262. doi: 10.1016/j.brs.2018.10.017. Epub 2018 Nov 3.

PMID:
30409712
4.

Computational Fluid Dynamics of Vascular Disease in Animal Models.

Acuna A, Berman AG, Damen FW, Meyers BA, Adelsperger AR, Bayer KC, Brindise MC, Bungart B, Kiel AM, Morrison RA, Muskat JC, Wasilczuk KM, Wen Y, Zhang J, Zito P, Goergen CJ.

J Biomech Eng. 2018 Aug 1;140(8). doi: 10.1115/1.4039678. Review.

PMID:
29570754
5.

Efficacy of radiosensitizing doped titania nanoparticles under hypoxia and preparation of an embolic microparticle.

Morrison RA, Rybak-Smith MJ, Thompson JM, Thiebaut B, Hill MA, Townley HE.

Int J Nanomedicine. 2017 May 18;12:3851-3863. doi: 10.2147/IJN.S127341. eCollection 2017.

6.

Traumatic Brain Injury Occludes Training-Dependent Cortical Reorganization in the Contralesional Hemisphere.

Pruitt DT, Danaphongse TT, Schmid AN, Morrison RA, Kilgard MP, Rennaker RL 2nd, Hays SA.

J Neurotrauma. 2017 Sep;34(17):2495-2503. doi: 10.1089/neu.2016.4796. Epub 2017 Jul 19.

7.

Forelimb training drives transient map reorganization in ipsilateral motor cortex.

Pruitt DT, Schmid AN, Danaphongse TT, Flanagan KE, Morrison RA, Kilgard MP, Rennaker RL 2nd, Hays SA.

Behav Brain Res. 2016 Oct 15;313:10-16. doi: 10.1016/j.bbr.2016.07.005. Epub 2016 Jul 5.

8.

Worry about recurrence in a multi-ethnic population of breast cancer survivors and their partners.

Janz NK, Li Y, Beesley LJ, Wallner LP, Hamilton AS, Morrison RA, Hawley ST.

Support Care Cancer. 2016 Nov;24(11):4669-78. doi: 10.1007/s00520-016-3314-z. Epub 2016 Jul 4.

PMID:
27378380
9.

Concomitant oral and intravenous pharmacokinetics of trametinib, a MEK inhibitor, in subjects with solid tumours.

Leonowens C, Pendry C, Bauman J, Young GC, Ho M, Henriquez F, Fang L, Morrison RA, Orford K, Ouellet D.

Br J Clin Pharmacol. 2014 Sep;78(3):524-32. doi: 10.1111/bcp.12373.

10.

Exposure to bloom-like concentrations of two marine Synechococcus cyanobacteria (strains CC9311 and CC9902) differentially alters fish behaviour.

Hamilton TJ, Paz-Yepes J, Morrison RA, Palenik B, Tresguerres M.

Conserv Physiol. 2014 Jun 5;2(1):cou020. doi: 10.1093/conphys/cou020. eCollection 2014.

11.

Metabolism and disposition of oral dabrafenib in cancer patients: proposed participation of aryl nitrogen in carbon-carbon bond cleavage via decarboxylation following enzymatic oxidation.

Bershas DA, Ouellet D, Mamaril-Fishman DB, Nebot N, Carson SW, Blackman SC, Morrison RA, Adams JL, Jurusik KE, Knecht DM, Gorycki PD, Richards-Peterson LE.

Drug Metab Dispos. 2013 Dec;41(12):2215-24. doi: 10.1124/dmd.113.053785. Epub 2013 Oct 4.

PMID:
24097902
12.

Trametinib, a first-in-class oral MEK inhibitor mass balance study with limited enrollment of two male subjects with advanced cancers.

Ho MY, Morris MJ, Pirhalla JL, Bauman JW, Pendry CB, Orford KW, Morrison RA, Cox DS.

Xenobiotica. 2014 Apr;44(4):352-68. doi: 10.3109/00498254.2013.831143. Epub 2013 Aug 23.

PMID:
23971497
13.

Concomitant oral and intravenous pharmacokinetics of dabrafenib, a BRAF inhibitor, in patients with BRAF V600 mutation-positive solid tumors.

Denton CL, Minthorn E, Carson SW, Young GC, Richards-Peterson LE, Botbyl J, Han C, Morrison RA, Blackman SC, Ouellet D.

J Clin Pharmacol. 2013 Sep;53(9):955-61. doi: 10.1002/jcph.127. Epub 2013 Jul 12.

PMID:
23846776
14.

The blood chemical status of Atlantic cod Gadus morhua following capture by jig and demersal longline with differential hook removal methods.

Mandelman JW, Morrison RA, Cavin JM, Farrington MA.

J Fish Biol. 2012 Sep;81(4):1406-14. doi: 10.1111/j.1095-8649.2012.03422.x.

PMID:
22957878
15.

Ketoconazole and rifampin significantly affect the pharmacokinetics, but not the safety or QTc interval, of casopitant, a neurokinin-1 receptor antagonist.

Johnson BM, Adams LM, Zhang K, Gainer SD, Kirby LC, Blum RA, Apseloff G, Morrison RA, Schutz RA, Lebowitz PF.

J Clin Pharmacol. 2010 Aug;50(8):951-9. doi: 10.1177/0091270009353761. Epub 2010 Feb 2.

PMID:
20124517
16.

The impact of protein on Caco-2 permeability of low mass balance compounds for absorption projection and efflux substrate identification.

Liu T, Chang LJ, Uss A, Chu I, Morrison RA, Wang L, Prelusky D, Cheng KC, Li C.

J Pharm Biomed Anal. 2010 Apr 6;51(5):1069-77. doi: 10.1016/j.jpba.2009.12.006. Epub 2009 Dec 24.

PMID:
20036089
17.

Permeability evaluation of peptidic HCV protease inhibitors in Caco-2 cells-correlation with in vivo absorption predicted in humans.

Li C, Liu T, Broske L, Brisson JM, Uss AS, Njoroge FG, Morrison RA, Cheng KC.

Biochem Pharmacol. 2008 Dec 15;76(12):1757-64. doi: 10.1016/j.bcp.2008.09.005. Epub 2008 Sep 13.

PMID:
18835257
18.

Application and interpretation of hPXR screening data: Validation of reporter signal requirements for prediction of clinically relevant CYP3A4 inducers.

Cui X, Thomas A, Gerlach V, White RE, Morrison RA, Cheng KC.

Biochem Pharmacol. 2008 Sep 1;76(5):680-9. doi: 10.1016/j.bcp.2008.06.016. Epub 2008 Jul 3.

PMID:
18647599
19.

Correlation between PAMPA permeability and cellular activities of hepatitis C virus protease inhibitors.

Li C, Nair L, Liu T, Li F, Pichardo J, Agrawal S, Chase R, Tong X, Uss AS, Bogen S, Njoroge FG, Morrison RA, Cheng KC.

Biochem Pharmacol. 2008 Mar 1;75(5):1186-97. doi: 10.1016/j.bcp.2007.10.031. Epub 2007 Nov 7.

PMID:
18164692
20.

Modulation of tight junctions does not predict oral absorption of hydrophilic compounds: use of Caco-2 and Calu-3 cells.

Kamath AV, Morrison RA, Mathias NR, Dando SA, Marino AM, Chong S.

Arch Pharm Res. 2007 Aug;30(8):1002-7.

PMID:
17879754
21.

Ultra-performance liquid chromatography/tandem mass spectrometric determination of diastereomers of SCH 503034 in monkey plasma.

Wang G, Hsieh Y, Cheng KC, Morrison RA, Venkatraman S, Njoroge FG, Heimark L, Korfmacher WA.

J Chromatogr B Analyt Technol Biomed Life Sci. 2007 Jun 1;852(1-2):92-100. Epub 2007 Jan 10.

PMID:
17240204
22.

Quantitative PCR assay for cytochromes P450 2B and 3A induction in rat precision-cut liver slices: correlation study with induction in vivo.

Cui X, Thomas A, Han Y, Palamanda J, Montgomery D, White RE, Morrison RA, Cheng KC.

J Pharmacol Toxicol Methods. 2005 Sep-Oct;52(2):234-43. Epub 2005 Apr 1.

PMID:
16125621
23.

Rat PXR reporter-gene activity correlates with the induction of CYP3A in rat precision-cut liver slices.

Cui X, Thomas A, Montgomery D, Gu C, Morrison RA, White RE, Cheng KC.

Comb Chem High Throughput Screen. 2005 Jun;8(4):341-6.

PMID:
16101010
24.
25.

Application of structure-metabolism relationships in the identification of a selective endothelin A antagonist, BMS-193884, with favourable pharmacokinetic properties.

Humphreys WG, Obermeier MT, Barrish JC, Chong S, Marino AM, Murugesan N, Wang-Iverson D, Morrison RA.

Xenobiotica. 2003 Nov;33(11):1109-23.

PMID:
14660175
26.

Commonly used surfactant, Tween 80, improves absorption of P-glycoprotein substrate, digoxin, in rats.

Zhang H, Yao M, Morrison RA, Chong S.

Arch Pharm Res. 2003 Sep;26(9):768-72.

PMID:
14560928
27.

A rapid and sensitive LC/MS/MS assay for quantitative determination of digoxin in rat plasma.

Yao M, Zhang H, Chong S, Zhu M, Morrison RA.

J Pharm Biomed Anal. 2003 Aug 21;32(6):1189-97.

PMID:
12907263
28.

Oxidative activation of acylguanidine prodrugs: intestinal presystemic activation in rats limits absorption and can be inhibited by co-administration of ketoconazole.

Humphreys WG, Obermeier MT, Chong S, Kimball SD, Das J, Chen P, Moquin R, Han WC, Gedamke R, White RE, Morrison RA.

Xenobiotica. 2003 Jan;33(1):93-106.

PMID:
12519697
29.

Biphenylsulfonamide endothelin receptor antagonists. 4. Discovery of N-[[2'-[[(4,5-dimethyl-3-isoxazolyl)amino]sulfonyl]-4-(2-oxazolyl)[1,1'-biphenyl]- 2-yl]methyl]-N,3,3-trimethylbutanamide (BMS-207940), a highly potent and orally active ET(A) selective antagonist.

Murugesan N, Gu Z, Spergel S, Young M, Chen P, Mathur A, Leith L, Hermsmeier M, Liu EC, Zhang R, Bird E, Waldron T, Marino A, Koplowitz B, Humphreys WG, Chong S, Morrison RA, Webb ML, Moreland S, Trippodo N, Barrish JC.

J Med Chem. 2003 Jan 2;46(1):125-37.

PMID:
12502366
30.

Discovery of N-isoxazolyl biphenylsulfonamides as potent dual angiotensin II and endothelin A receptor antagonists.

Murugesan N, Tellew JE, Gu Z, Kunst BL, Fadnis L, Cornelius LA, Baska RA, Yang Y, Beyer SM, Monshizadegan H, Dickinson KE, Panchal B, Valentine MT, Chong S, Morrison RA, Carlson KE, Powell JR, Moreland S, Barrish JC, Kowala MC, Macor JE.

J Med Chem. 2002 Aug 29;45(18):3829-35.

PMID:
12190306
31.

Current methodologies used for evaluation of intestinal permeability and absorption.

Balimane PV, Chong S, Morrison RA.

J Pharmacol Toxicol Methods. 2000 Jul-Aug;44(1):301-12. Review.

PMID:
11274897
32.

A rapid screening system to determine drug affinities for the intestinal dipeptide transporter 2: affinities of ACE inhibitors.

Moore VA, Irwin WJ, Timmins P, Lambert PA, Chong S, Dando SA, Morrison RA.

Int J Pharm. 2000 Dec 4;210(1-2):29-44.

PMID:
11163985
33.

A rapid screening system to determine drug affinities for the intestinal dipeptide transporter 1: system characterisation.

Moore VA, Irwin WJ, Timmins P, Chong S, Dando SA, Morrison RA.

Int J Pharm. 2000 Dec 4;210(1-2):15-27.

PMID:
11163984
34.

Biphenylsulfonamide endothelin receptor antagonists. 2. Discovery of 4'-oxazolyl biphenylsulfonamides as a new class of potent, highly selective ET(A) antagonists.

Murugesan N, Gu Z, Stein PD, Spergel S, Mathur A, Leith L, Liu EC, Zhang R, Bird E, Waldron T, Marino A, Morrison RA, Webb ML, Moreland S, Barrish JC.

J Med Chem. 2000 Aug 10;43(16):3111-7.

PMID:
10956219
35.

Disposition of radiolabeled ifetroban in rats, dogs, monkeys, and humans.

Dockens RC, Santone KS, Mitroka JG, Morrison RA, Jemal M, Greene DS, Barbhaiya RH.

Drug Metab Dispos. 2000 Aug;28(8):973-80.

PMID:
10901709
36.

Continuous blood withdrawal as a rapid screening method for determining clearance of oral bioavailability in rats.

Humphreys WG, Obermeier MT, Morrison RA.

Pharm Res. 1998 Aug;15(8):1257-61.

PMID:
9706058
37.
38.

Intestinal absorption of captopril and two thioester analogs in rats and dogs.

Morrison RA, Kripalani KJ, Marino AM, Dean AV, Migdalof BH, Weinstein SH, Jain NB, Bathala MS, Singhvi SM.

Biopharm Drug Dispos. 1997 Jan;18(1):25-39.

PMID:
9008267
39.

Low blood pressure in Down's syndrome, A link with Alzheimer's disease?

Morrison RA, McGrath A, Davidson G, Brown JJ, Murray GD, Lever AF.

Hypertension. 1996 Oct;28(4):569-75.

PMID:
8843880
40.

Prodrugs of BMS-183920: metabolism and permeability considerations.

Obermeier MT, Chong S, Dando SA, Marino AM, Ryono DE, Starrett-Arroyo A, DiDonato GC, Warrack BM, White RE, Morrison RA.

J Pharm Sci. 1996 Aug;85(8):828-33.

PMID:
8863272
41.

Suitability of enalapril as a probe of the dipeptide transporter system: in vitro and in vivo studies.

Morrison RA, Chong S, Marino AM, Wasserman MA, Timmins P, Moore VA, Irwin WJ.

Pharm Res. 1996 Jul;13(7):1078-82.

PMID:
8842049
42.

Distribution of the dipeptide transporter system along the gastrointestinal tract of rats based on absorption of a stable and specific probe, SQ-29852.

Marino AM, Chong S, Dando SA, Kripalani KJ, Bathala MS, Morrison RA.

J Pharm Sci. 1996 Mar;85(3):282-6.

PMID:
8699329
43.
44.
45.

Update on sickle cell disease: incidence of addiction and choice of opioid in pain management.

Morrison RA.

Pediatr Nurs. 1991 Sep-Oct;17(5):503. No abstract available.

PMID:
1923659
46.

Sites of first-pass bioactivation (hydrolysis) of orally administered zofenopril calcium in dogs.

Morrison RA, Burkett DE, Arnold ME, D'Arienzo CJ, Weinstein SH.

Pharm Res. 1991 Mar;8(3):370-5.

PMID:
2052527
47.

Haploid plants from tissue culture. Application in crop improvement.

Morrison RA, Evans DA, Fan Z.

Subcell Biochem. 1991;17:53-72. Review. No abstract available.

PMID:
1796490
48.

Disposition of zofenopril calcium in healthy subjects.

Singhvi SM, Foley JE, Willard DA, Morrison RA.

J Pharm Sci. 1990 Nov;79(11):970-3.

PMID:
2292772
49.

Outpatient management of febrile illness in infants and young children with sickle cell anemia.

Rogers ZR, Morrison RA, Vedro DA, Buchanan GR.

J Pediatr. 1990 Nov;117(5):736-9. No abstract available.

PMID:
2121947
50.

Supplemental Content

Loading ...
Support Center